or Try an Advanced Search...

    Technical Analysis for TYP - Tryptamine Therapeutics Limited

    Grade Last Price % Change Price Change
    F 0.018 5.88% 0.001
    TYP closed up 5.88 percent on Thursday, October 3, 2024, on 50 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical TYP trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Wide Range Bar Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 5.88%
    Reversal New Lows Setup Bearish Swing Setup 5.88%
    Stochastic Buy Signal Bullish 5.88%
    Doji - Bearish? Reversal 5.88%
    Doji - Bullish? Reversal 5.88%
    New 52 Week Low Weakness 5.88%
    Older End-of-Day Signals for TYP ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance about 14 hours ago
    10 DMA Resistance about 14 hours ago
    Up 10% about 16 hours ago
    Lower Bollinger Band Support about 16 hours ago
    Rose Above Previous Day's High about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TYP Chart by TradingView
    Basic chart:

    Profile

    Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Development

    Is TYP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.025
    52 Week Low 0.017
    Average Volume 1,455,697
    200-Day Moving Average 0.000
    50-Day Moving Average 0.020
    20-Day Moving Average 0.019
    10-Day Moving Average 0.018
    Average True Range 0.001
    RSI (14) 52.61
    ADX 10.28
    +DI 30.233
    -DI 30.233
    Chandelier Exit (Long, 3 ATRs) 0.017
    Chandelier Exit (Short, 3 ATRs) 0.020
    Upper Bollinger Bands 0.020
    Lower Bollinger Band 0.017
    Percent B (%b) 0.34
    BandWidth 17.297
    MACD Line -0.001
    MACD Signal Line 0.000
    MACD Histogram -0.0001
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.021
    Resistance 3 (R3) 0.021 0.020 0.021
    Resistance 2 (R2) 0.020 0.019 0.020 0.020
    Resistance 1 (R1) 0.019 0.019 0.020 0.019 0.020
    Pivot Point 0.018 0.018 0.018 0.018 0.018
    Support 1 (S1) 0.017 0.017 0.018 0.017 0.016
    Support 2 (S2) 0.016 0.017 0.016 0.016
    Support 3 (S3) 0.015 0.016 0.016
    Support 4 (S4) 0.015